1. Home
  2. GLMD vs NVFY Comparison

GLMD vs NVFY Comparison

Compare GLMD & NVFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • NVFY
  • Stock Information
  • Founded
  • GLMD 2000
  • NVFY 2003
  • Country
  • GLMD Israel
  • NVFY United States
  • Employees
  • GLMD N/A
  • NVFY N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • NVFY Home Furnishings
  • Sector
  • GLMD Health Care
  • NVFY Consumer Discretionary
  • Exchange
  • GLMD Nasdaq
  • NVFY Nasdaq
  • Market Cap
  • GLMD 4.5M
  • NVFY 3.9M
  • IPO Year
  • GLMD 2014
  • NVFY N/A
  • Fundamental
  • Price
  • GLMD $1.46
  • NVFY $0.60
  • Analyst Decision
  • GLMD
  • NVFY
  • Analyst Count
  • GLMD 0
  • NVFY 0
  • Target Price
  • GLMD N/A
  • NVFY N/A
  • AVG Volume (30 Days)
  • GLMD 2.6M
  • NVFY 1.7M
  • Earning Date
  • GLMD 05-29-2025
  • NVFY 05-14-2025
  • Dividend Yield
  • GLMD N/A
  • NVFY N/A
  • EPS Growth
  • GLMD N/A
  • NVFY N/A
  • EPS
  • GLMD N/A
  • NVFY N/A
  • Revenue
  • GLMD N/A
  • NVFY $9,686,975.00
  • Revenue This Year
  • GLMD N/A
  • NVFY N/A
  • Revenue Next Year
  • GLMD N/A
  • NVFY N/A
  • P/E Ratio
  • GLMD N/A
  • NVFY N/A
  • Revenue Growth
  • GLMD N/A
  • NVFY N/A
  • 52 Week Low
  • GLMD $1.33
  • NVFY $0.39
  • 52 Week High
  • GLMD $23.80
  • NVFY $3.73
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 33.38
  • NVFY 49.70
  • Support Level
  • GLMD $1.33
  • NVFY $0.64
  • Resistance Level
  • GLMD $1.55
  • NVFY $0.75
  • Average True Range (ATR)
  • GLMD 0.33
  • NVFY 0.10
  • MACD
  • GLMD -0.04
  • NVFY 0.01
  • Stochastic Oscillator
  • GLMD 5.90
  • NVFY 42.11

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

About NVFY Nova Lifestyle Inc.

Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.

Share on Social Networks: